News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Frontage Laboratories Expands Early-Phase Clinical Capabilities to Support Global Drug Development
Saturday, January 31, 2026Frontage Laboratories has expanded its earlyphase clinical research capabilities in the United States and China to better support global drug development The move strengthens the companys ability to deliver faster and highquality
European Commission Approves Gazyva/Gazyvaro for Adults with Active Lupus Nephritis in Groundbreaking Regulatory Milestone
Thursday, January 29, 2026The European Commission has approved GazyvaGazyvaro for adults with active lupus nephritis marking a significant advancement in treatment options for this autoimmune condition
Immix Biopharma Secures US FDA Breakthrough Therapy Designation for NXC-201
Thursday, January 29, 2026Immix Biopharma has received Breakthrough Therapy Designation from the US Food and Drug Administration for NXC for the treatment of relapsed or refractory AL amyloidosis
Boehringer Ingelheim and Simcere Partner to Advance Dual-Target Antibody for Inflammatory Bowel Disease
Wednesday, January 28, 2026Boehringer Ingelheim and Simcere Pharmaceutical Group have entered into a licensing and collaboration agreement to develop SIM a preclinical bispecific antibody for the treatment of inflammatory bowel disease IBD
European Commission Extends Marketing Authorisation for Bracco Imaging's Vueway (Gadopiclenol) to Pediatric Patients Under 2 Years
Tuesday, January 27, 2026The European Commission has expanded the EU approval of Bracco Imagings Vueway gadopiclenol to include pediatric patients from birth highlighting its positive benefitrisk profile in young children
Mair Therapeutics Partners with Radboud University to Advance TMEM175 Agonists for Parkinson’s Disease
Tuesday, January 27, 2026Mair Therapeutics a biotechnology company based in the Netherlands has entered into a scientific collaboration with Radboud University to speed up the discovery of smallmolecule TMEM agonists for the treatment of Parkinsons disease
Improved Drug Safety in European Pharma Requires Enhanced Data Before AI Integration
Friday, January 23, 2026European life sciences experts emphasize the urgent need for comprehensive highquality safety data to enable effective AI applications in drug development and regulatory compliance
Isomorphic Labs Enters Research Collaboration with Johnson & Johnson to Advance AI-Driven Drug Discovery
Wednesday, January 21, 2026Isomorphic Labs has entered into a crossmodality multitarget research collaboration with Johnson Johnson The partnership brings together Isomorphic Labs AIfirst drug discovery approach with Johnson Johnsons strengths
EQT Life Sciences Co-Leads EUR 51 Million Series B Funding for Exciva to Advance Alzheimer's Therapy into Phase 2 Clinical Trials
Tuesday, January 20, 2026EQT Life Sciences coleads a EUR million Series B investment in Exciva to propel its Alzheimers disease therapy into Phase clinical development
Hoth Therapeutics Achieves Key EU Regulatory Milestone Advancing HT-001 Oncology Trial Across Multiple European Countries
Friday, January 16, 2026Hoth Therapeutics has received a positive regulatory conclusion under the EU Clinical Trials Information System for its HT program paving the way for multicountry site activation in Hungary Spain and Poland
